298 related articles for article (PubMed ID: 35136951)
1. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency.
Maresh K; Papageorgiou A; Ridout D; Harrison NA; Mandy W; Skuse D; Muntoni F
Brain; 2023 Jan; 146(1):252-265. PubMed ID: 35136951
[TBL] [Abstract][Full Text] [Related]
2. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel startle response task in Duchenne muscular dystrophy.
Maresh K; Papageorgiou A; Ridout D; Harrison N; Mandy W; Skuse D; Muntoni F
PLoS One; 2022; 17(4):e0264091. PubMed ID: 35439255
[TBL] [Abstract][Full Text] [Related]
4. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes.
Chaussenot R; Edeline JM; Le Bec B; El Massioui N; Laroche S; Vaillend C
Neurobiol Learn Mem; 2015 Oct; 124():111-22. PubMed ID: 26190833
[TBL] [Abstract][Full Text] [Related]
5. Brain function in Duchenne muscular dystrophy.
Anderson JL; Head SI; Rae C; Morley JW
Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
[TBL] [Abstract][Full Text] [Related]
6. Live-imaging of revertant and therapeutically restored dystrophin in the Dmd
Petkova MV; Stantzou A; Morin A; Petrova O; Morales-Gonzalez S; Seifert F; Bellec-Dyevre J; Manoliu T; Goyenvalle A; Garcia L; Richard I; Laplace-Builhé C; Schuelke M; Amthor H
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):602-614. PubMed ID: 32573804
[TBL] [Abstract][Full Text] [Related]
7. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
[TBL] [Abstract][Full Text] [Related]
8. Intelligence quotient-genotype association in dystrophinopathies: A systematic review and meta-analysis.
Pascual-Morena C; Cavero-Redondo I; Sequí-Domínguez I; Rodríguez-Gutiérrez E; Visier-Alfonso ME; Martínez-Vizcaíno V
Neuropathol Appl Neurobiol; 2023 Jun; 49(3):e12914. PubMed ID: 37312416
[TBL] [Abstract][Full Text] [Related]
9. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
Hiyoshi T; Zhao F; Baba R; Hirakawa T; Kuboki R; Suzuki K; Tomimatsu Y; O'Donnell P; Han S; Zach N; Nakashima M
Skelet Muscle; 2023 Nov; 13(1):19. PubMed ID: 37980539
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
11. Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.
Ricotti V; Jägle H; Theodorou M; Moore AT; Muntoni F; Thompson DA
Eur J Hum Genet; 2016 Apr; 24(4):562-8. PubMed ID: 26081639
[TBL] [Abstract][Full Text] [Related]
12. Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy.
Hashimoto Y; Kuniishi H; Sakai K; Fukushima Y; Du X; Yamashiro K; Hori K; Imamura M; Hoshino M; Yamada M; Araki T; Sakagami H; Takeda S; Itaka K; Ichinohe N; Muntoni F; Sekiguchi M; Aoki Y
Prog Neurobiol; 2022 Sep; 216():102288. PubMed ID: 35654209
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.
Wu WC; Bradley SP; Christie JM; Pugh JR
J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002
[TBL] [Abstract][Full Text] [Related]
14. Urine titin as a novel biomarker for Duchenne muscular dystrophy.
Ishii MN; Nakashima M; Kamiguchi H; Zach N; Kuboki R; Baba R; Hirakawa T; Suzuki K; Quinton M
Neuromuscul Disord; 2023 Apr; 33(4):302-308. PubMed ID: 36871413
[TBL] [Abstract][Full Text] [Related]
15. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
[TBL] [Abstract][Full Text] [Related]
16. Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta-analysis.
Pascual-Morena C; Cavero-Redondo I; Álvarez-Bueno C; Jiménez-López E; Saz-Lara A; Martínez-García I; Martínez-Vizcaíno V
Dev Med Child Neurol; 2023 Jun; 65(6):734-744. PubMed ID: 36440509
[TBL] [Abstract][Full Text] [Related]
17. The long dystrophin gene product Dp427 modulates retinal function and vascular morphology in response to age and retinal ischemia.
Bucher F; Friedlander MSH; Aguilar E; Kurihara T; Krohne TU; Usui Y; Friedlander M
Neurochem Int; 2019 Oct; 129():104489. PubMed ID: 31199961
[TBL] [Abstract][Full Text] [Related]
18. Dp71 and intellectual disability in Indonesian patients with Duchenne muscular dystrophy.
Iskandar K; Triono A; Sunartini ; Dwianingsih EK; Indraswari BW; Kirana IR; Ivana G; Sutomo R; Patria SY; Herini ES; Gunadi
PLoS One; 2022; 17(10):e0276640. PubMed ID: 36315559
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization of dystrophin isoforms in cardiomyocytes and phenotypic analysis of dystrophin-deficient mice reveal cardiac myopathy is predominantly caused by a deficiency in full-length dystrophin.
Masubuchi N; Shidoh Y; Kondo S; Takatoh J; Hanaoka K
Exp Anim; 2013; 62(3):211-7. PubMed ID: 23903056
[TBL] [Abstract][Full Text] [Related]
20. Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy.
Crawford AH; Hildyard JCW; Rushing SAM; Wells DJ; Diez-Leon M; Piercy RJ
Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 35019137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
